ARVO 2021: Oral Treatment With Montelukast Linked to Decreased Risk of Diabetic Retinopathy
The leukotriene receptor antagonist may decrease the odds of diabetic retinopathy by blocking pro-inflammatory cascades
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.